Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients.
Conclusions: TNF-α seems to be a useful marker to evaluate the efficacy of therapy and occurring resistance to the medicine. A complex mechanism for the regulation of the analysed gene expression was underlined, which involved the potential role of miRNAs.
PMID: 33240014 [PubMed]
Source: Advances in Dermatology and Allergology - Category: Dermatology Tags: Postepy Dermatol Alergol Source Type: research
More News: Databases & Libraries | Dermatology | Genetics | Humira | Molecular Biology | Psoriasis | Skin | Study